Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Parnetti

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 28, 2003
Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitorsL Parnetti, S Amici, A Lanari, et al.
Archives of Gerontology and Geriatrics|November 1, 1992
Idebenone in senile dementia of Alzheimer type: a multicentre studyU Senin, L Parnetti, G Barbagallo-Sangiorgi, et al.
Acta Neurologica Scandinavica|October 1, 2010
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's diseaseL Parnetti, D Chiasserini, U Andreasson, et al.
European Journal of Neurology|August 21, 2010
A magnetization transfer study of mild and advanced Parkinson's diseaseN Tambasco, V Belcastro, P Sarchielli, et al.
Neurology|October 31, 2008
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsyB Borroni, M Malinverno, F Gardoni, et al.
Neuromolecular Medicine|October 5, 2007
Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patientsD Caccamo, G Gorgone, M Currò, et al.
Journal of Neuroscience Research|April 22, 2003
Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's diseaseJ Sáez-Valero, L R Fodero, M Sjögren, et al.
Alzheimer Disease and Associated Disorders|December 28, 1999
Vascular dementia: the role of cerebral infarctsD Leys, T Erkinjuntti, D W Desmond, et al.
Acta Neurologica Scandinavica|June 1, 1996
Posatirelin in the treatment of vascular dementia: a double-blind multicentre study vs placeboL Parnetti, L Ambrosoli, G Agliati, et al.
European Neurology|September 4, 1999
White matter changes in stroke patients. Relationship with stroke subtype and outcomeD Leys, E Englund, T Del Ser, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 28, 2003
Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitorsL Parnetti, S Amici, A Lanari, et al.
Archives of Gerontology and Geriatrics|November 1, 1992
Idebenone in senile dementia of Alzheimer type: a multicentre studyU Senin, L Parnetti, G Barbagallo-Sangiorgi, et al.
Acta Neurologica Scandinavica|October 1, 2010
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's diseaseL Parnetti, D Chiasserini, U Andreasson, et al.
European Journal of Neurology|August 21, 2010
A magnetization transfer study of mild and advanced Parkinson's diseaseN Tambasco, V Belcastro, P Sarchielli, et al.
Neurology|October 31, 2008
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsyB Borroni, M Malinverno, F Gardoni, et al.
Neuromolecular Medicine|October 5, 2007
Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patientsD Caccamo, G Gorgone, M Currò, et al.
Journal of Neuroscience Research|April 22, 2003
Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's diseaseJ Sáez-Valero, L R Fodero, M Sjögren, et al.
Alzheimer Disease and Associated Disorders|December 28, 1999
Vascular dementia: the role of cerebral infarctsD Leys, T Erkinjuntti, D W Desmond, et al.
Acta Neurologica Scandinavica|June 1, 1996
Posatirelin in the treatment of vascular dementia: a double-blind multicentre study vs placeboL Parnetti, L Ambrosoli, G Agliati, et al.
European Neurology|September 4, 1999
White matter changes in stroke patients. Relationship with stroke subtype and outcomeD Leys, E Englund, T Del Ser, et al.
Pageof 12